DOCSLIB.ORG

1199SEIU Benefit Funds Cardiology & Radiology Code List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
1199SEIU Benefit Funds Cardiology & Radiology Code List 1199SEIU Benefit Funds Claims Management Procedure List: Cardiology & Radiology Included w/ Category CPT® Code CPT® Code Description Claims Management 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, 3D Imaging 76377 or other tomographic modality with image postprocessing under concurrent supervision; requiring image X postprocessing on an independent workstation 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, 3D Imaging 76376 or other tomographic modality with image postprocessing under concurrent supervision; not requiring image X postprocessing on an independent workstation Magnetic resonance imaging, breast, without and with contrast material(s), including computer-aided detection BMRI 77049 X (CAD real-time lesion detection, characterization and pharmacokinetic analysis), when performed; bilateral Magnetic resonance imaging, breast, without and with contrast material(s), including computer-aided detection BMRI 77048 X (CAD real-time lesion detection, characterization and pharmacokinetic analysis), when performed; unilateral BMRI 77047 Magnetic resonance imaging, breast, without contrast material; bilateral X BMRI 77046 Magnetic resonance imaging, breast, without contrast material; unilateral X Use of echocardiographic contrast agent during stress echocardiography (List separately in addition to code for Cardiac Services 93352 X primary procedure) Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically Cardiac Services 93351 X induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when Cardiac Services 93350 performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically X induced stress, with interpretation and report; Cardiac Services 93325 Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) X Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to Cardiac Services 93321 codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for X echocardiographic imaging) Effective: 1/1/2020 Included w/ Category CPT® Code CPT® Code Description Claims Management Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to Cardiac Services 93320 X codes for echocardiographic imaging); complete Echocardiography, transesophageal (TEE) for monitoring purposes, including probe placement, real time 2- Cardiac Services 93318 dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically X changing) cardiac pumping function and to therapeutic measures on an immediate time basis Transesophageal echocardiography for congenital cardiac anomalies; image acquisition, interpretation and report Cardiac Services 93317 X only Cardiac Services 93316 Transesophageal echocardiography for congenital cardiac anomalies; placement of transesophageal probe only X Transesophageal echocardiography for congenital cardiac anomalies; including probe placement, image Cardiac Services 93315 X acquisition, interpretation and report Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); Cardiac Services 93314 X image acquisition, interpretation and report only Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); Cardiac Services 93313 X placement of transesophageal probe only Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); Cardiac Services 93312 X including probe placement, image acquisition, interpretation and report Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when Cardiac Services 93308 X performed, follow-up or limited study Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when Cardiac Services 93307 X performed, complete, without spectral or color Doppler echocardiography Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when Cardiac Services 93306 X performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography Cardiac Services 93304 Transthoracic echocardiography for congenital cardiac anomalies; follow-up or limited study X Cardiac Services 93303 Transthoracic echocardiography for congenital cardiac anomalies; complete X Contrast Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g.
Load more

Recommended publications
  • Resting Coronary Flow Velocity in The
    European Heart Journal – Cardiovascular Imaging (2012) 13,79–85 CLINICAL/ORIGINAL PAPERS doi:10.1093/ehjci/jer153 Resting coronary flow velocity in the functional evaluation of coronary artery stenosis: study on sequential use of computed tomography angiography and transthoracic Doppler Downloaded from https://academic.oup.com/ehjcimaging/article/13/1/79/2397059 by guest on 30 September 2021 echocardiography Esa Joutsiniemi 1, Antti Saraste 1,2*, Mikko Pietila¨ 1, Heikki Ukkonen 1,2, Sami Kajander 2, Maija Ma¨ki 2,3, Juha Koskenvuo 3, Juhani Airaksinen 1, Jaakko Hartiala 3, Markku Saraste 3, and Juhani Knuuti 2 1Department of Cardiology, Turku University Hospital, Kiinamyllynkatu 4-8, 20520 Turku, Finland; 2Turku PET Centre, Kiinamyllynkatu 4-8, 20520 Turku, Finland; and 3Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Kiinamyllynkatu 4-8, 20520 Turku, Finland Received 10 March 2011; accepted after revision 2 August 2011; online publish-ahead-of-print 30 August 2011 Aims Accelerated flow at the site of flow-limiting stenosis can be detected by transthoracic Doppler echocardiography (TTDE). We studied feasibility and accuracy of sequential coronary computed tomography angiography (CTA) and TTDE in detection of haemodynamically significant coronary artery disease (CAD). ..................................................................................................................................................................................... Methods We prospectively enrolled 107 patients with intermediate (30–70%) pre-test likelihood of CAD. All patients under- and results went CTA using a 64-slice scanner. Using TTDE, the ratio of maximal diastolic flow velocity to pre-stenotic flow velocity (M/P ratio) was measured in the coronary segments with stenosis in CTA. In all patients, the results were compared with invasive coronary angiography, including measurement of fractional flow reserve when appropriate.
    [Show full text]
  • Clinical Review Karen Bleich NDA 020351 Supplement 44 (CCTA) Visipaque (Iodixanol)
    Clinical Review Karen Bleich NDA 020351 Supplement 44 (CCTA) Visipaque (iodixanol) CLINICAL REVIEW Application Type Supplemental New Drug Application Application Number(s) NDA 020351 s44 Priority or Standard Priority Submit Date(s) October 6th, 2016 Received Date(s) October 18th, 2016 PDUFA Goal Date April 5th, 2017 Division/Office Division of Medical Imaging Products/Office of Drug Evaluation IV Reviewer Name(s) Karen Bleich, MD Review Completion Date March 10th, 2017 Established Name Iodixanol (Proposed) Trade Name Visipaque Injection Applicant GE Healthcare Formulation(s) 320 mgI/mL Dosing Regimen 70-80 mL main bolus volume (does not include optional test bolus volume of 20 mL) at a flow rate of(b) (4) mL/s, followed by 20 mL saline flush Applicant Proposed For use in coronary computed tomography angiography (CCTA) to Indication(s)/Population(s) assist in the diagnostic evaluation of patients with suspected coronary artery disease. Recommendation on Approval Regulatory Action Recommended For use in coronary computed tomography angiography (CCTA) to Indication(s)/Population(s) assist in the diagnostic evaluation of patients with suspected (if applicable) coronary artery disease. CDER Clinical Review Template 2015 Edition 1 Reference ID: 4068412 Clinical Review Karen Bleich NDA 020351 Supplement 44 (CCTA) Visipaque (iodixanol) Table of Contents Glossary ........................................................................................................................................... 8 1 Executive Summary ..............................................................................................................
    [Show full text]
  • The Challenge of Assessing Heart Valve Prostheses by Doppler Echocardiography
    Editorial Comment The Challenge of Assessing Heart Valve Prostheses by Doppler Echocardiography Helmut Baumgartner, MD, Muenster, Germany The assessment of prosthetic valve function remains challenging. by continuous-wave Doppler measurement. Using these velocities Echocardiography has become the key diagnostic tool not only be- for the calculation of transvalvular gradients results in marked overes- cause of its noninvasive nature and wide availability but also because timation of the actual pressure drop across the prostheses.6 The fact of limitations inherent in alternative diagnostic techniques. Invasive that this phenomenon more or less disappears in malfunctioning bi- evaluation is limited particularly in mechanical valves that cannot leaflet prostheses when the funnel-shaped central flow channel ceases be crossed with a catheter, and in patients with both aortic and mitral to exist because of restricted leaflet motion makes the interpretation valve replacements, full hemodynamic assessment would even of Doppler data and their use for accurate detection of prosthesis mal- require left ventricular puncture. Although fluoroscopy and more function even more complicated.7 Furthermore, the lack of a flat ve- recently computed tomography allow the visualization of mechanical locity profile and the central high velocities described above cause valves and the motion of their occluders, the evaluation of prosthetic erroneous calculations of valve areas when the continuity equation valves typically relies on Doppler echocardiography. incorporates such measurements.8 For these reasons, the analysis of Although Doppler echocardiography has become an ideal nonin- occluder motion using fluoroscopy (in mitral prostheses, this may vasive technique for the evaluation of native heart valves and their also be obtained on transesophageal echocardiography) remains es- function, the assessment of prosthetic valves has remained more dif- sential to avoid the misinterpretation of high Doppler velocities across ficult.
    [Show full text]
  • 2Nd Quarter 2001 Medicare Part a Bulletin
    In This Issue... From the Intermediary Medical Director Medical Review Progressive Corrective Action ......................................................................... 3 General Information Medical Review Process Revision to Medical Record Requests ................................................ 5 General Coverage New CLIA Waived Tests ............................................................................................................. 8 Outpatient Hospital Services Correction to the Outpatient Services Fee Schedule ................................................................. 9 Skilled Nursing Facility Services Fee Schedule and Consolidated Billing for Skilled Nursing Facility (SNF) Services ............. 12 Fraud and Abuse Justice Recovers Record $1.5 Billion in Fraud Payments - Highest Ever for One Year Period ........................................................................................... 20 Bulletin Medical Policies Use of the American Medical Association’s (AMA’s) Current Procedural Terminology (CPT) Codes on Contractors’ Web Sites ................................................................................. 21 Outpatient Prospective Payment System January 2001 Update: Coding Information for Hospital Outpatient Prospective Payment System (OPPS) ......................................................................................................................... 93 he Medicare A Bulletin Providers Will Be Asked to Register Tshould be shared with all to Receive Medicare Bulletins and health care
    [Show full text]
  • Coronary Artery Calcium Quantification in Contrast-Enhanced Computed Tomography Angiography
    Georgia State University ScholarWorks @ Georgia State University Computer Science Dissertations Department of Computer Science 12-18-2013 Coronary Artery Calcium Quantification in Contrast-enhanced Computed Tomography Angiography Abinashi Dhungel Georgia State University Follow this and additional works at: https://scholarworks.gsu.edu/cs_diss Recommended Citation Dhungel, Abinashi, "Coronary Artery Calcium Quantification in Contrast-enhanced Computed Tomography Angiography." Dissertation, Georgia State University, 2013. https://scholarworks.gsu.edu/cs_diss/80 This Dissertation is brought to you for free and open access by the Department of Computer Science at ScholarWorks @ Georgia State University. It has been accepted for inclusion in Computer Science Dissertations by an authorized administrator of ScholarWorks @ Georgia State University. For more information, please contact [email protected]. CORONARY ARTERY CALCIUM QUANTIFICATION IN CONTRAST-ENHANCED COMPUTED TOMOGRAPHY ANGIOGRAPHY by ABINASHI DHUNGEL Under the Direction of Dr. Michael Weeks ABSTRACT Coronary arteries are the blood vessels supplying oxygen-rich blood to the heart muscles. Coronary artery calcium (CAC), which is the total amount of calcium deposited in these arteries, indicates the presence or the future risk of coronary artery diseases. Quantification of CAC is done by using computed tomography (CT) scan which uses attenuation of x- ray by different tissues in the body to generate three-dimensional images. Calcium can be easily spotted in the CT images because of its higher opacity to x-ray compared to that of the surrounding tissue. However, the arteries cannot be identified easily in the CT images. Therefore, a second scan is done after injecting a patient with an x-ray opaque dye known as contrast material which makes different chambers of the heart and the coronary arteries visible in the CT scan.
    [Show full text]
  • June-July 2000 Part a Bulletin
    In This Issue... Disclosure of Itemized Statement Providers Must Furnish an Itemmized Statement when Requested in Writing by the Beneficiary .................................................................................................... 6 Prospective Payment System The Outpatient Code Editor Software Has Been Modified in Preparation for the Implementation of Outpatient Prospective Payment System ........................... 8 Reclassification of Certain Urban Hospitals Certain Urban Hospitals in the State of Florida May Be Permitted to Be Reclassified as Rural Hospitals................................................................................ 13 ulletin Final Medical Review Policies 33216, 53850, 70541, 82108, 83735, 87621, 93303, 94010, 95004, A0320, J0207, J2430, J2792, J3240, J7190, and J9999 .......................................... 15 B Payment of Skilled Nursing Facility Claims Involving a Terminating Medicare+Choice Plan Payment of Skilled Nursing Facility Care for Beneficiaries Involuntarily Disenrolling from M+C plans Who Have Not Met the 3-Day Stay Requirement ........................................................................................... 67 Features From the Medical Director 3 Administrative 4 lease share the Medicare A roviders PBulletin with appropriate General Information 5 members of your organization. Outpatient Prospective Payment System 7 Routing Suggestions: General Coverage 12 o Medicare Manager Hospital Services 13 o Reimbursement Director Local and Focused Medical Policies 15 o Chief Financial
    [Show full text]
  • Assessment of Myocardial Perfusion by Contrast Echocardiography - Ready for Clinical Practice?
    Journal of Clinical and Basic Cardiology An Independent International Scientific Journal Journal of Clinical and Basic Cardiology 2002; 5 (2), 145-148 Assessment of Myocardial Perfusion by Contrast Echocardiography - Ready for Clinical Practice? Kuntz-Hehner St, Becher H, Luederitz B, Omran H Schlosser Th, Tiemann K Homepage: www.kup.at/jcbc Online Data Base Search for Authors and Keywords Indexed in Chemical Abstracts EMBASE/Excerpta Medica Krause & Pachernegg GmbH · VERLAG für MEDIZIN und WIRTSCHAFT · A-3003 Gablitz/Austria FOCUS ON NEW DEVELOPMENTS IN ECHOCARDIOGRAPHY Contrast Echocardiographic Myocardial Perfusion Assessment J Clin Basic Cardiol 2002; 5: 145 Assessment of Myocardial Perfusion by Contrast Echocardiography – Ready for Clinical Practice? St. Kuntz-Hehner1, K. Tiemann1, Th. Schlosser1, H. Omran1, B. Luederitz1, H. Becher2 Increasing interest has been focused on myocardial contrast echocardiography (MCE) since latest ultrasound-specific imaging modalities allow the detection of ultrasound contrast agents within the myocardium after intravenous injection. Due to significant improvements in imaging technology MCE has become a valuable add-on tool for the diagnosis of coronary artery disease. This review summarizes and estimates the clinical value of recent developments in myocardial contrast echocardiography, particularly with regard to the new real-time perfusion imaging, which allows simultaneous assessment of perfusion and wall- motion. J Clin Basic Cardiol 2002; 5: 145–8. Key words: echocardiography, coronary artery disease, ultrasound contrast agent, myocardial contrast echocardiography, myocardial perfusion he assessment of myocardial perfusion following intra- nals in a process known as stimulated acoustic emission [12– T venous injection of ultrasound contrast agents (USCAs) 15]. has been a major objective of research in the last two decades.
    [Show full text]
  • Dual Imaging Stress Echocardiography Versus Computed
    Ciampi et al. Cardiovascular Ultrasound (2015) 13:21 DOI 10.1186/s12947-015-0013-8 CARDIOVASCULAR ULTRASOUND RESEARCH Open Access Dual imaging stress echocardiography versus computed tomography coronary angiography for risk stratification of patients with chest pain of unknown origin Quirino Ciampi1,2*, Fausto Rigo3, Elisabetta Grolla3, Eugenio Picano2 and Lauro Cortigiani4 Abstract Background: Dual imaging stress echocardiography, combining the evaluation of wall motion and coronary flow reserve (CFR) on the left anterior descending artery (LAD), and computed tomography coronary angiography (CTCA) are established techniques for assessing prognosis in chest pain patients. In this study we compared the prognostic value of the two methods in a cohort of patients with chest pain having suspected coronary artery disease (CAD). Methods: A total of 131 patients (76 men; age 68 ± 9 years) with chest pain of unknown origin underwent dipyridamole (up to 0.84 mg/kg over 6 min) stress echo with CFR assessment of LAD by Doppler and CTCA. A CFR ≤ 1.9 was considered abnormal, while > 50% lumen diameter reduction was the criterion for significant CAD at CTCA. Results: Of 131 patients, 34 (26%) had ischemia at stress echo (new wall motion abnormalities), and 56 (43%) had reduced CFR on LAD. Significant coronary stenosis at CTCA was found in 69 (53%) patients. Forty-six patients (84%) with abnormal CFR on LAD showed significant CAD at CTCA (p < 0.001). Calcium score was higher in patients with reduced than in those with normal CFR (265 ± 404 vs 131 ± 336, p = 0.04). During a median follow-up of 7 months (1st to 3rd quartile: 5–13 months), there were 45 major cardiac events (4 deaths, 11 nonfatal myocardial infarctions, and 30 late [≥6 months] coronary revascularizations).
    [Show full text]
  • Influence of Cardiac Hemodynamic Parameters on Coronary Artery
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by RERO DOC Digital Library Eur Radiol (2006) 16: 1111–1116 DOI 10.1007/s00330-005-0110-4 CARDIAC Lars Husmann Influence of cardiac hemodynamic parameters Hatem Alkadhi Thomas Boehm on coronary artery opacification with 64-slice Sebastian Leschka Tiziano Schepis computed tomography Pascal Koepfli Lotus Desbiolles Borut Marincek Philipp A. Kaufmann Simon Wildermuth Abstract The purpose of this study artery. A significant negative correla- Received: 13 September 2005 Revised: 21 November 2005 was to evaluate the influence of tion was found in both arteries between Accepted: 29 November 2005 ejection fraction (EF), stroke volume SV and attenuation (RCA r=−0.26, Published online: 28 January 2006 (SV), heart rate, and cardiac output P<0.05; LMA r=−0.34, P<0.01) and # Springer-Verlag 2006 (CO) on coronary artery opacification between SV and CNR (RCA r=−0.26, L. Husmann . H. Alkadhi (*) . with 64-slice computed tomography P<0.05; LMA r=−0.26, P<0.05). T. Boehm . S. Leschka . (CT). Sixty patients underwent, retro- Similarly, a significant negative cor- L. Desbiolles . B. Marincek Department of Medical Radiology, spectively, electrocardiography-gated relation was found between the CO and Institute of Diagnostic Radiology, 64-slice CT coronary angiography. attenuation (RCA r=−0.42, P<0.05; University Hospital of Zurich, Left ventricular EF, SV, and CO LMA r=−0.56, P<0.001) and between Raemistrasse 100, were calculated with semi-automated the CO and CNR (RCA r=−0.39, 8091 Zurich, Switzerland software.
    [Show full text]
  • Blood Flow Hemodynamics, Cardiac Mechanics, and Doppler Echocardiography
    79351_CH04_Bulwer.qxd 12/1/09 7:46 AM Page 45 CHAPTER 4 Blood Flow Hemodynamics, Cardiac Mechanics, and Doppler Echocardiography THE CARDIAC CYCLE Figure 4.1 The cardiac cycle showing superimposed hemody- namic and echocardio- graphic parameters. A4C: apical 4-chamber view; A5C: apical 5-chamber view; AC: aortic valve clo- sure; AO: aortic valve opening; E- and A-waves: spectral Doppler depiction of early and late diastolic filling of the left ventricle; MC: mitral valve closure; MO: mitral valve opening; LA: left atrium; LV: left ven- tricle; left atrial “a” and “e” waves reflecting atrial pressures; EDV: end dias- tolic LV volume; ESV: end- systolic LV volume. © Jones and Bartlett Publishers, LLC. NOT FOR SALE OR DISTRIBUTION. 79351_CH04_Bulwer.qxd 12/1/09 7:46 AM Page 46 46 CHAPTER 4 BLOOD FLOW HEMODYNAMICS Figure 4.2 Flow velocity profiles in normal pulsatile blood flow. Normal blood flow through the heart and blood vessels, at any instant in time, is not uniform. There is a range or spectrum of velocities at each instant during the cardiac cycle. This spectrum, at each instant during the cardiac cycle, can be differentiated and displayed using Doppler echocardiography (see Figures 4.3–4.22). © Jones and Bartlett Publishers, LLC. NOT FOR SALE OR DISTRIBUTION. 79351_CH04_Bulwer.qxd 12/1/09 7:46 AM Page 47 Blood Flow Velocity Profiles 47 BLOOD FLOW VELOCITY PROFILES Doppler echocardiography can assess blood flow velocity, direction and flow patterns/profiles (e.g., plug), and laminar, parabolic, and turbulent flow Figures 4.3–4.19 . Crucial to understanding Doppler echocardiography is the need to understand certain basic characteristics of blood flow.
    [Show full text]
  • 2019 FAQ EP Coding and Reimbursement Physicians and Facilities RESOURCES to ASSIST YOU with the REIMBURSEMENT PROCESS
    2019 FAQ EP Coding and Reimbursement Physicians and Facilities RESOURCES TO ASSIST YOU WITH THE REIMBURSEMENT PROCESS Reimbursement and Coding and Reimbursement Electrophysiology EP Procedure Documentation Coding Guide Frequently Asked Questions Coding Checklist Best Practices Online HCPCS C-Code Finder Coding & Reimbursement Webinars Email your Coding Questions www.biosensewebster.com/reimbursement 2 TABLE OF CONTENTS ABLATION PROCEDURES 4 - 6 ELECTROPHYSIOLOGY STUDIES 8 - 11 MAPPING 12 TRANSSEPTAL ACCESS 13 ECHOCARDIOGRAPHY (TEE AND ICE) 14 - 17 HCPCS CODES (C-CODES) 18 - 19 MISCELLANEOUS 20 - 21 PROCEDURE VIGNETTES 22 - 25 ® ASSIGNMENT OF CPT CODES TO APC CATEGORIES 26 - 27 GLOSSARY AND ACRONYMS 28 - 29 REIMBURSEMENT METHODOLOGIES 30 - 31 CODING RESOURCES AND REFERENCES 32 The information is provided to assist you in understanding the reimbursement process. It is intended to assist providers in accurately obtaining reimbursement for health care services. It is not intended to increase or maximize reimbursement by any payer. We strongly suggest that you consult your payer organization with regard to local reimbursement policies. The information contained in this document is provided for information purposes only and represents no statement, promise or guarantee by Biosense Webster, Inc. concerning levels of reimbursement, payment or charge. Similarly, all CPT® & HCPCS codes are supplied for information purposes only and represent no statement; promise or guarantee by Biosense Webster, Inc. that these codes will be appropriate or that reimbursement will be made. Third party trademarks used herein are trademarks of their respective owners. www.biosensewebster.com/reimbursement 3 ABLATION PROCEDURES PROCEDURES ABLATION Q. What CPT® codes are reported for ablation procedures? A. As a result of the Joint CPT® / RUC screen for procedures inherently performed together, three primary codes were introduced in 2013 which bundle electrophysiological (EP) evaluation and intracardiac ablation procedures, as well as two add-on ablation codes.
    [Show full text]
  • Radiation Dose to Adults from Common Imaging Examinations
    Radiation Dose to Adults From Common Imaging Examinations Approximate Approximate comparable time of Procedure effective radiation natural background dose (mSv) radiation exposure Computed Tomography (CT) — Abdomen and Pelvis 7.7 mSv 2.6 years Computed Tomography (CT) — Abdomen and Pelvis, 15.4 mSv 5.1 years repeated with and without contrast material ABDOMINAL Computed Tomography (CT) — Colonography 6 mSv 2 years REGION Intravenous Pyelogram (IVP) 3 mSv 1 year Barium Enema (Lower GI X-ray) 6 mSv 2 years Upper GI Study With Barium 6 mSv 2 years Lumbar Spine 1.4 mSv 6 months BONE Extremity (hand, foot, etc.) X-ray < 0.001 mSv < 3 hours Computed Tomography (CT) — Brain 1.6 mSv 7 months Computed Tomography (CT) — Brain, repeated with CENTRAL 3.2 mSv 13 months NERVOUS and without contrast material SYSTEM Computed Tomography (CT) — Head and Neck 1.2 mSv 5 months Computed Tomography (CT) — Spine 8.8 mSv 3 years Computed Tomography (CT) — Chest 6.1 mSv 2 years CHEST Computed Tomography (CT) — Lung Cancer Screening 1.5 mSv 6 months Chest X-ray 0.1 mSv 10 days Dental X-ray 0.005 mSv 1 day DENTAL Panoramic X-Ray 0.025 mSv 3 days Cone Beam CT 0.18 mSv 22 days Coronary Computed Tomography Angiography (CTA) 8.7 mSv 3 years HEART Cardiac CT for Calcium Scoring 1.7 mSv 6 months Non-Cardiac Computed Tomography Angiography (CTA) 5.1 mSv < 2 years MEN’S IMAGING Bone Densitometry (DEXA) 0.001 mSv 3 hours NUCLEAR Positron Emission Tomography — Computed Tomography 22.7 mSv 3.3 years MEDICINE (PET/CT) Whole body protocol Bone Densitometry (DEXA) 0.001 mSv 3 hours WOMEN’S Screening Digital Mammography 0.21 mSv 26 days IMAGING Screening Digital Breast Tomosynthesis 0.27 mSv 33 days (3-D Mammogram) Note: This chart simplifies a highly complex topic for patients’ informational use.
    [Show full text]